[go: up one dir, main page]

EP1019041A4 - Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains - Google Patents

Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains

Info

Publication number
EP1019041A4
EP1019041A4 EP98920311A EP98920311A EP1019041A4 EP 1019041 A4 EP1019041 A4 EP 1019041A4 EP 98920311 A EP98920311 A EP 98920311A EP 98920311 A EP98920311 A EP 98920311A EP 1019041 A4 EP1019041 A4 EP 1019041A4
Authority
EP
European Patent Office
Prior art keywords
mind
raise
people
methods
behavioral behavior
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP98920311A
Other languages
German (de)
English (en)
Other versions
EP1019041A1 (fr
Inventor
Ladislav Volicer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Unimed Pharmaceuticals LLC
Original Assignee
Unimed Pharmaceuticals LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/866,511 external-priority patent/US5804592A/en
Application filed by Unimed Pharmaceuticals LLC filed Critical Unimed Pharmaceuticals LLC
Publication of EP1019041A1 publication Critical patent/EP1019041A1/fr
Publication of EP1019041A4 publication Critical patent/EP1019041A4/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/658—Medicinal preparations containing organic active ingredients o-phenolic cannabinoids, e.g. cannabidiol, cannabigerolic acid, cannabichromene or tetrahydrocannabinol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
EP98920311A 1997-05-07 1998-05-06 Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains Withdrawn EP1019041A4 (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US4581397P 1997-05-07 1997-05-07
US45813P 1997-05-07
US866511 1997-05-30
US08/866,511 US5804592A (en) 1997-05-30 1997-05-30 Method for improving disturbed behavior and elevating mood in humans
PCT/US1998/009269 WO1998050027A1 (fr) 1997-05-07 1998-05-06 Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains

Publications (2)

Publication Number Publication Date
EP1019041A1 EP1019041A1 (fr) 2000-07-19
EP1019041A4 true EP1019041A4 (fr) 2002-04-17

Family

ID=26723227

Family Applications (1)

Application Number Title Priority Date Filing Date
EP98920311A Withdrawn EP1019041A4 (fr) 1997-05-07 1998-05-06 Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains

Country Status (6)

Country Link
EP (1) EP1019041A4 (fr)
JP (1) JP2002501510A (fr)
AU (1) AU743788B2 (fr)
CA (1) CA2288693A1 (fr)
IL (1) IL132784A (fr)
WO (1) WO1998050027A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12459965B2 (en) 2017-10-09 2025-11-04 Compass Pathfinder Limited Preparation of psilocybin, different polymorphic forms, intermediates, formulations and their use
GB2571696B (en) 2017-10-09 2020-05-27 Compass Pathways Ltd Large scale method for the preparation of Psilocybin and formulations of Psilocybin so produced
US20210023053A1 (en) 2018-03-30 2021-01-28 India Globalization Capital, Inc. Method and composition for treating cns disorders
CN113993523A (zh) 2019-04-17 2022-01-28 指南针探路者有限公司 用赛洛西宾治疗抑郁症和其他各种病症

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0427518A1 (fr) * 1989-11-07 1991-05-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Composés de NMDA-blocage, compositions pharmaceutiques, leur préparation et leur usage
WO1995020958A1 (fr) * 1994-02-07 1995-08-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Derives de dexanabinol et leur emploi en tant que compositions pharmaceutiques neuroprotectrices

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5596106A (en) * 1994-07-15 1997-01-21 Eli Lilly And Company Cannabinoid receptor antagonists

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0427518A1 (fr) * 1989-11-07 1991-05-15 Yissum Research Development Company Of The Hebrew University Of Jerusalem Composés de NMDA-blocage, compositions pharmaceutiques, leur préparation et leur usage
WO1995020958A1 (fr) * 1994-02-07 1995-08-10 Ramot University Authority For Applied Research And Industrial Development Ltd. Derives de dexanabinol et leur emploi en tant que compositions pharmaceutiques neuroprotectrices

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
"Study finds Dronabinol promising in Alzheimer disease", JOURNAL OF PHARMACY TECHNOLOGY, CINCINNATI, OH, US, vol. 12, no. 6, November 1996 (1996-11-01), pages 294, XP002114257, ISSN: 8755-1225 *
RUPNIAK ET AL.: "Induction of cognitive impairment by scopolamine and noncholinergic agents in Rhesus monkeys", LIFE SCIENCES, vol. 48, no. 9, 1991, pages 893 - 899, XP008000795 *
See also references of WO9850027A1 *
VOLICER ET AL.: "Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease", INT. J. GERIATRIC PSY., vol. 12, no. 9, September 1997 (1997-09-01), pages 913 - 919, XP008000789 *
VOLICER ET AL.: "Effects of dronabinol on anorexia and disturbed behavior in patients with Alzheimer's disease", NEUROBIOLOGY OF AGING, vol. 17, no. 4supl., 1996, pages s73 - s74, XP008000790 *
VOLICER L: "Dronabinol may help behavior problems in Alzheimer's disease", AMERICAN FAMILY PHYSICIAN, AMERICAN ACADEMY OF FAMILY PHYSICIANS, US, vol. 55, no. 4, March 1997 (1997-03-01), pages 1338, XP002114258 *

Also Published As

Publication number Publication date
IL132784A0 (en) 2001-03-19
CA2288693A1 (fr) 1998-11-12
AU7291698A (en) 1998-11-27
JP2002501510A (ja) 2002-01-15
EP1019041A1 (fr) 2000-07-19
IL132784A (en) 2004-07-25
WO1998050027A1 (fr) 1998-11-12
AU743788B2 (en) 2002-02-07

Similar Documents

Publication Publication Date Title
DE69819332D1 (de) VERBESSERTE ANTIKÖRPER GEGEN IgE UND VERFAHREN ZUR VERBESSERUNG VON ANTIKÖRPERN
DE59810847D1 (de) Verfahren zur form- und volumengebung von humanhaaren
DE69700813D1 (de) Verwendung von stabilen aminofunktionellen latexen in wässrigen tinten
EP0963202A4 (fr) Formulations et methodes pour assurer une anesthesie locale prolongee
DE69824312D1 (de) Verfahren und gerät zur beendigung von tachyarrhythmien
NO995742L (no) Emulsjon for behandling i broenner og formasjoner
NL300395I2 (nl) GnRH antagonisten gemodificeerd in posities 5 en 6
DE69531497D1 (de) Verfahren zur spaltenbildung in und stützung von lagerstätten
DE69511860D1 (de) Modifizierung von clostridium-toxinen und ihre anwendung als transport proteine
BR9507590A (pt) Métodos e meio em ascensores em escada
ATA116194A (de) Fluxbitumen und bitumenemulsion
DE69800995D1 (de) Verfahren und vorrichtung zur direkten umsetzung von uranhexafluorid in uranoxid
DE69701802D1 (de) Paralleler prozessor mit redundanz von prozessorpaaren und verfahren
DE59506178D1 (de) Verfahren und vorrichtung zur rekonstruktion von in rasterform vorliegenden linienstrukturen
DE69932427D1 (de) Verfahren und testen verwendbar bei der behandlung von alkoholabhängigkeit oder -missbrauch
DE69624243D1 (de) Verwendung von unverdaulichen oligosacchariden zur vorbeugung und behandlung von mittelohrentzündung bei menschen
DE69823110D1 (de) Verfahren zur Dokumentwiedergabe und Zeichenextrahierung
DE69737469D1 (de) Diffundierter Titanwiderstand und Herstellungsmethode
DE69535434D1 (de) Allergieauslösendes Protein Hev b II aus natürlichem Gummi-Latex, Herstellung und Anwendung in Nachweismethoden
DE69817779D1 (de) Einbringung von rauchmodifizierenden mitteln in rauchartikeln
EP1019041A4 (fr) Procede d'amelioration de comportements perturbes et de stimulation de l'humeur chez des humains
DE69812256D1 (de) 7-propyl-benzodiosepin-3-one und dessen Verwendung in Parfümerie
DE69400004D1 (de) Vorrichtung zum Saugen und Speichern von Abfällen.
DE69627655D1 (de) Schneidelement, stopfen und verfahren zur verhinderung des eindringens von spül-schlamm in das schneidelement
KR960010685A (ko) 펩티드 및 그 용도

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19991207

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

A4 Supplementary search report drawn up and despatched

Effective date: 20020305

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE

17Q First examination report despatched

Effective date: 20021007

17Q First examination report despatched

Effective date: 20021007

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20070519